P6.1 Monitoring Torque Teno Virus viral loads in pediatric renal transplant recipients: A pilot study
Jaythoon Hassan, Ireland
P6.2 Single center experience of surveillance biopsies in pediatric kidney transplants
Mr. Nathaniel Zona, United States
P6.3 New onset diabetes after transplant in a single pediatric kidney transplant center
Dr. Anjali Khanna-Farber, United States
P6.4 Post Kidney Transplant cardiovascular proactive screening- does it make a difference?
Miss Louise Kipping, United Kingdom
P6.5 Post Kidney Transplant cardiovascular service – proactive screening in paediatric recipients
Miss Louise Kipping, United Kingdom
P6.7 Influence of migration status on practice and clinical course of pediatric kidney transplantation
Dr. Sara Testa, Italy
P6.8 Graft loss due to isolated Angio-invasive Aspergillosis of Kidney Allograft following Normothermic Machine Perfusion of Neonatal En-bloc kidney after Uncontrolled Circulatory Determination of Death
Dr. Devprakash Choudhary, India
P6.9 A single center experience with MicKey button vesicostomy in pediatric kidney transplant recipients
Mrs. Brittney Grabowski, United States
P6.10 Are hemodynamic targets related to renal-injury biomarker excretion during pediatric kidney transplantation?
Mrs. Elisabeth Marlies Cornelissen, Netherlands
P6.11 Early impact of the COVID-19 pandemic on UK paediatric kidney transplantation
Dr. Helen E. Jones, United Kingdom
P6.12 Obinutuzumab as Adjunct Therapy for Recurrent FSGS after Kidney Transplantation
Dr. Agnieszka Swiatecka-Urban, United States
P6.13 Utilization of subcutaneous immunoglobulin G in antibody mediated rejection treatment
Dr. Katherine E. Twombley, United States
P6.14 Short-term renal allograft outcome in adolescents with nephropathic cystinosis: a single center longitudinal study
Dr. Kiran Upadhyay, United States
P6.15 Post-transplant infections following induction with ATG in an emerging pediatric renal transplant program
Dr. Indira Agarwal, India
P6.16 Treatment of refractory acute rejection with local graft irradiation in pediatric kidney transplant patients: A case series
Dr. David K. Hooper, United States
P6.17 Dynamic changes in cell free-DNA: A clinical case report utilizing dd-cfDNA for allograft surveillance
Dr. German Lozano, United States
P6.18 Clinical characteristics associated with metabolic acidosis in pediatric kidney transplant recipients
Dr. Stella Kilduff, United States
P6.19 Thrombotic microangiopathy after pediatric renal transplantation: report of 2 cases
Dr. Veronica A. Bravo Diaz, Argentina
P6.20 Decanting Enteral Feeds
Mrs. Nicolle L. Quinn, United States
P6.22 Utilization of dd-cfDNA for survelliance in a teenaged pediatric population
Dr. German Lozano, United States
P6.23 Observational Case Series on Utilizing C1 Esterase Inhibitor for Prevention of Delayed Graft Function In Pediatric Renal Transplantation
Dr. Dechu Puliyanda, United States
P6.24 Prevalence of nocturnal hypertension in pediatric kidney transplant patients using 2022 ABPM guidelines